Cynosure Inc (CYNO) 33.89 $CYNO
North American Dermatology Devices (Dermatology Treatment Devices, Dermatology Diagnostic Devices) Market 2015 - Forecast to 2019
M2 - Fri Apr 24, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk922d/north_american) has announced the addition of the "North American Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices) - Forecast to 2019" report to their offering. The North American dermatology diagnostic devices market is estimated to grow at a CAGR of 7.9% from 2014 to 2019 Although mature markets (the U.S. and Canada) command larger shares in the dermatology diagnostic devices market, Mexico is expected to grow at the highest CAGR of 9.8% during the forecast period. The growth of the dermatology diagnostic devices market is driven by factors such as rising incidences of skin disorders, increasing demand for diagnosis by baby boomers, need for more dermatologists, and technological advancements. However, factors such as lack of awareness, competitive pricing, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology diagnostic devices market has been broadly classified on the basis of types. This segment includes dermatoscopes, imaging techniques, and microscopes. The imaging techniques segment commands the largest share of the dermatology diagnostic devices market, growing at a CAGR of 8.0% during the forecast period (2014 to 2019). This large share is mainly due to the fact that imaging techniques are generally in vivo tools and helps in the detection of later stages of skin disorders. The U.S commanded the largest share of 89.3% of the North American dermatology diagnostic devices market in 2014, followed by Canada. The dermatology diagnostic devices market in the U.S. is primarily driven by the increasing demand from baby boomers and increasing insurance coverage for citizens due to increasing employment. Mexico is the fastest-growing segment in the North American region, at a CAGR of 9.8% during the forecast period. This is due to the increasing insurance coverage and awareness of various skin disorders in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North America Dermatology Devices Market, By Type 6 North America Dermatology Devices Market, By Geography 7 North America Dermatology Devices Market: Competitive Landscape 8 Dermatology Devices Market, By Company - Alma Lasers, Ltd. - Ambicare Health Ltd - Amd Global Telemedicine Inc. - Applisonix Ltd. - Biolitec Ag - Carl Zeiss Meditec - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Photomedex, Inc. - Solta Medical, - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/bk...h_american
ELOS: 12.05 (-0.04), CYNO: 33.89 (+0.66), LMNS: 11.51 (+0.24)
Cynosure Announces Late-Breaking Abstracts on New Non-Invasive Fat Reduction Technology at ASLMS Annual Conference
PR Newswire - Wed Apr 22, 7:30AM CDT
Cynosure, Inc. (NASDAQ: CYNO) today announced that three presentations on the Company's new laser technology for non-invasive fat reduction will be delivered at LASER 2015, the 35th Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS). The event takes place today through April 26 at the Gaylord Palms Resort & Convention Center in Kissimmee, Florida.
CYNO: 33.89 (+0.66)
Global Dermatology Device Market Outlook 2020
M2 - Thu Apr 16, 7:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hbnv8t/global) has announced the addition of the "Global Dermatology Device Market Outlook 2020" report to their offering. In 2014, the Global Dermatology Device market was valued at US$ 6.8 Billion in 2014 which is projected to grow at a CAGR of around 12% in till 2020. Inclining consumer awareness and acceptance rates of minimally and non-invasive treatments and increasing demand of aesthetic procedures such as body contouring, skin tightening and skin rejuvenation will drive the market in the coming years. However, on the other hand, strict government regulations and inappropriate reimbursement policies, especially in emerging economies, may hinder the growth of the dermatology device market. Geographically, we have covered three major regions including North America, Europe, and Asia. Rising occurrence of skin related ailments along with technological advancements and higher healthcare expenditures have resulted in North America being the largest market for dermatology devices. This trend is expected to continue. The market in Asia-Pacific is anticipated to be most profitable due to highly untapped opportunities, rising patient awareness, improvement in healthcare infrastructure. Inclining disorders such as acne, dermatitis, skin warts, lesions and moles, especially in China and India, is projected to drive the Asian market. In the end, we have showcased market share of major players and company profiles of various key players have been enlisted. Our team has analyzed each company's business overview and financial performance along with its recent developments, and strengths and weaknesses that will help the readers better position their company vis-?-vis the competitors. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Dermatology Devices: A Brief Overview 4. Drivers 5. Challenges 6. Global Dermatology Devices Market Outlook to 2020 7. Government Regulations 8. New Product Development 9. Acquisitions 10. Competitive Landscape - Cynosure Inc. - Syneron Medical - Cutera - Lumenis - PhotoMedex - Carl Zeiss For more information visit http://www.researchandmarkets.com/research/hbnv8t/global
ELOS: 12.05 (-0.04), CYNO: 33.89 (+0.66), PHMD: 2.05 (+0.09)
Cynosure To Host First-Quarter 2015 Financial Results Conference Call On May 5
PR Newswire - Wed Apr 15, 7:30AM CDT
Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today announced that the Company will release its first-quarter 2015 financial results before the market opens on Tuesday, May 5, 2015 and host a conference call for investors and analysts that day at 9:00 a.m. ET.
CYNO: 33.89 (+0.66)
My Top Health Care Equipment And Supplies Stocks For 2015
Stan Stafford - at Seeking Alpha - Fri Apr 10, 12:52PM CDT
ZMH: 118.76 (+0.19), SIRO: 94.43 (+0.13), ABMD: 68.83 (-0.74), BDX: 144.33 (-0.02), MASI: 34.83 (-0.07), IRIX: 10.02 (+0.19), ALGN: 59.18 (+3.17), CYNO: 33.89 (+0.66), GB: 55.62 (-0.35), EW: 138.33 (-3.59), ANIK: 38.35 (-0.32), ERB: 2.89 (+0.07), BABY: 42.15 (-0.01), GMED: 24.79 (+0.15), BAX: 71.14 (-0.37), STJ: 73.47 (-0.54), INGN: 37.13 (+0.11)
BUYINS.NET: HALL, MPEL, AMRI, KLIC, CYNO, NHI Expected To Be Up Before Next Earnings Releases
M2 - Wed Apr 08, 6:56AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and May earnings reports. Hallmark Financial Services Inc (NASDAQ:HALL), Melco Crown Entertainment Limited (NASDAQ:MPEL), Albany Molecular Research Inc (NASDAQ:AMRI), Kulicke and Soffa Industries Inc (NASDAQ:KLIC), CYNOSURE INC (NASDAQ:CYNO), National Health Investors Inc (NYSE:NHI) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up Before earnings are released Thursday:
KLIC: 15.49 (-0.19), CYNO: 33.89 (+0.66), HALL: 11.27 (-0.01), MPEL: 21.99 (+0.07), NHI: 69.49 (+0.50), AMRI: 19.08 (+0.04)
Cynosure Shares Up 25.4% Since SmarTrend's Buy Recommendation (CYNO)
Comtex SmarTrend(R) - Thu Mar 12, 5:06PM CDT
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 5 months, Cynosure has returned 25.37% as of today's recent price of $28.66.
CYNO: 33.89 (+0.66)
Uptrend Call Working As Cynosure Stock Rises 36.7% (CYNO)
Comtex SmarTrend(R) - Thu Feb 19, 9:12AM CST
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 4 months, Cynosure has returned 36.70% as of today's recent price of $31.25.
CYNO: 33.89 (+0.66)
Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
AVP: 9.02 (+0.03), CYNO: 33.89 (+0.66), CS: 26.16 (-0.48), ATU: 23.89 (-0.38), CRK: 4.63 (-0.04)
Dermatology Devices Market worth $11,337.0 Million by 2019
M2 - Thu Feb 12, 8:19AM CST
"Major Players of Dermatology Devices Market are Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Genesis Biosystems, Inc. (U.S.), HEINE Optotechnik GmbH & Co. KG (Germany), Lumenis Ltd. (Israel), Michelson Diagnostics (U.K.), PhotoMedex, Inc. (U.S.), and Solta Medical, Inc. (U.S.)"The report segments the global dermatology devices market on the basis of applications, products, and geographies. he report provides a granular understanding of the dermatology devices market.
CYNO: 33.89 (+0.66), LMNS: 11.51 (+0.24), PHMD: 2.05 (+0.09)
Cynosure Up 34.1% Since SmarTrend Uptrend Call (CYNO)
Comtex SmarTrend(R) - Tue Feb 10, 5:00PM CST
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 4 months, Cynosure has returned 34.08% as of today's recent price of $30.65.
CYNO: 33.89 (+0.66)
Cynosure's (CYNO) CEO Mike Davin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 10, 2:07PM CST
CYNO: 33.89 (+0.66)
Cynosure (CYNO) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 10, 7:55AM CST
CYNO: 33.89 (+0.66)
Cynosure posts 4Q profit
Automated Insights - Tue Feb 10, 7:36AM CST
WESTFORD, Mass. (AP) _ Cynosure Inc. (CYNO) on Tuesday reported fourth-quarter earnings of $23 million.
CYNO: 33.89 (+0.66)
Cynosure misses by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 7:02AM CST
CYNO: 33.89 (+0.66)
Cynosure Reports Record Quarterly Revenue of $86.3 Million for the Fourth Quarter of 2014
PR Newswire - Tue Feb 10, 7:00AM CST
Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three and 12 months ended December 31, 2014.
CYNO: 33.89 (+0.66)
Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:30PM CST
WYN: 91.33 (+0.56), TLM: 7.89 (+0.01), CYNO: 33.89 (+0.66), PCG: 52.74 (+0.55), KKR: 23.39 (-0.15), GWR: 95.31 (-1.15), CDW: 38.87 (-0.15), ALLT: 8.68 (-0.25), HOT: 83.13 (-0.21), SAVE: 77.42 (+0.43), NSP: 50.80 (-0.91), MWW: 6.28 (-0.20), ACM: 33.18 (-0.22), DF: 16.83 (-0.03), REGN: 480.09 (+0.01), KO: 40.89 (-0.06), MLM: 138.53 (+0.29), RAI: 76.26 (-0.71), HCP: 42.45 (-0.12), SEE: 44.74 (-0.05), ENTG: 13.61 (-0.13), TAP: 75.13 (+0.01), ALR: 49.97 (-0.04), HNT: 58.28 (+0.41), OMC: 77.50 (-0.30), IMN: 4.16 (-0.11), SALE: 19.03 (+0.02), NILE: 28.37 (+0.87), CVS: 101.58 (+0.70), SFUN: 8.04 (-0.52)
Cynosure to Participate in Leerink Global Healthcare Conference
PR Newswire - Mon Feb 09, 7:30AM CST
Cynosure, Inc. (NASDAQ: CYNO) today announced that Chairman and Chief Executive Officer Michael Davin and Tim Baker, the Company's President and Chief Financial Officer, will participate in the Leerink Global Healthcare Conference in New York City.
CYNO: 33.89 (+0.66)
Shares of CYNO Up 33.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 03, 11:13AM CST
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 3 months, Cynosure has returned 33.38% as of today's recent price of $30.49.
CYNO: 33.89 (+0.66)
North American Dermatology Devices (Dermatology Treatment Devices, Dermatology Diagnostic Devices) Market 2015 - Forecast to 2019
M2 - Fri Apr 24, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk922d/north_american) has announced the addition of the "North American Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices) - Forecast to 2019" report to their offering. The North American dermatology diagnostic devices market is estimated to grow at a CAGR of 7.9% from 2014 to 2019 Although mature markets (the U.S. and Canada) command larger shares in the dermatology diagnostic devices market, Mexico is expected to grow at the highest CAGR of 9.8% during the forecast period. The growth of the dermatology diagnostic devices market is driven by factors such as rising incidences of skin disorders, increasing demand for diagnosis by baby boomers, need for more dermatologists, and technological advancements. However, factors such as lack of awareness, competitive pricing, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology diagnostic devices market has been broadly classified on the basis of types. This segment includes dermatoscopes, imaging techniques, and microscopes. The imaging techniques segment commands the largest share of the dermatology diagnostic devices market, growing at a CAGR of 8.0% during the forecast period (2014 to 2019). This large share is mainly due to the fact that imaging techniques are generally in vivo tools and helps in the detection of later stages of skin disorders. The U.S commanded the largest share of 89.3% of the North American dermatology diagnostic devices market in 2014, followed by Canada. The dermatology diagnostic devices market in the U.S. is primarily driven by the increasing demand from baby boomers and increasing insurance coverage for citizens due to increasing employment. Mexico is the fastest-growing segment in the North American region, at a CAGR of 9.8% during the forecast period. This is due to the increasing insurance coverage and awareness of various skin disorders in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North America Dermatology Devices Market, By Type 6 North America Dermatology Devices Market, By Geography 7 North America Dermatology Devices Market: Competitive Landscape 8 Dermatology Devices Market, By Company - Alma Lasers, Ltd. - Ambicare Health Ltd - Amd Global Telemedicine Inc. - Applisonix Ltd. - Biolitec Ag - Carl Zeiss Meditec - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Photomedex, Inc. - Solta Medical, - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/bk...h_american
ELOS: 12.05 (-0.04), CYNO: 33.89 (+0.66), LMNS: 11.51 (+0.24)
Cynosure Announces Late-Breaking Abstracts on New Non-Invasive Fat Reduction Technology at ASLMS Annual Conference
PR Newswire - Wed Apr 22, 7:30AM CDT
Cynosure, Inc. (NASDAQ: CYNO) today announced that three presentations on the Company's new laser technology for non-invasive fat reduction will be delivered at LASER 2015, the 35th Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS). The event takes place today through April 26 at the Gaylord Palms Resort & Convention Center in Kissimmee, Florida.
CYNO: 33.89 (+0.66)
Global Dermatology Device Market Outlook 2020
M2 - Thu Apr 16, 7:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hbnv8t/global) has announced the addition of the "Global Dermatology Device Market Outlook 2020" report to their offering. In 2014, the Global Dermatology Device market was valued at US$ 6.8 Billion in 2014 which is projected to grow at a CAGR of around 12% in till 2020. Inclining consumer awareness and acceptance rates of minimally and non-invasive treatments and increasing demand of aesthetic procedures such as body contouring, skin tightening and skin rejuvenation will drive the market in the coming years. However, on the other hand, strict government regulations and inappropriate reimbursement policies, especially in emerging economies, may hinder the growth of the dermatology device market. Geographically, we have covered three major regions including North America, Europe, and Asia. Rising occurrence of skin related ailments along with technological advancements and higher healthcare expenditures have resulted in North America being the largest market for dermatology devices. This trend is expected to continue. The market in Asia-Pacific is anticipated to be most profitable due to highly untapped opportunities, rising patient awareness, improvement in healthcare infrastructure. Inclining disorders such as acne, dermatitis, skin warts, lesions and moles, especially in China and India, is projected to drive the Asian market. In the end, we have showcased market share of major players and company profiles of various key players have been enlisted. Our team has analyzed each company's business overview and financial performance along with its recent developments, and strengths and weaknesses that will help the readers better position their company vis-?-vis the competitors. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Dermatology Devices: A Brief Overview 4. Drivers 5. Challenges 6. Global Dermatology Devices Market Outlook to 2020 7. Government Regulations 8. New Product Development 9. Acquisitions 10. Competitive Landscape - Cynosure Inc. - Syneron Medical - Cutera - Lumenis - PhotoMedex - Carl Zeiss For more information visit http://www.researchandmarkets.com/research/hbnv8t/global
ELOS: 12.05 (-0.04), CYNO: 33.89 (+0.66), PHMD: 2.05 (+0.09)
Cynosure To Host First-Quarter 2015 Financial Results Conference Call On May 5
PR Newswire - Wed Apr 15, 7:30AM CDT
Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today announced that the Company will release its first-quarter 2015 financial results before the market opens on Tuesday, May 5, 2015 and host a conference call for investors and analysts that day at 9:00 a.m. ET.
CYNO: 33.89 (+0.66)
My Top Health Care Equipment And Supplies Stocks For 2015
Stan Stafford - at Seeking Alpha - Fri Apr 10, 12:52PM CDT
ZMH: 118.76 (+0.19), SIRO: 94.43 (+0.13), ABMD: 68.83 (-0.74), BDX: 144.33 (-0.02), MASI: 34.83 (-0.07), IRIX: 10.02 (+0.19), ALGN: 59.18 (+3.17), CYNO: 33.89 (+0.66), GB: 55.62 (-0.35), EW: 138.33 (-3.59), ANIK: 38.35 (-0.32), ERB: 2.89 (+0.07), BABY: 42.15 (-0.01), GMED: 24.79 (+0.15), BAX: 71.14 (-0.37), STJ: 73.47 (-0.54), INGN: 37.13 (+0.11)
BUYINS.NET: HALL, MPEL, AMRI, KLIC, CYNO, NHI Expected To Be Up Before Next Earnings Releases
M2 - Wed Apr 08, 6:56AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and May earnings reports. Hallmark Financial Services Inc (NASDAQ:HALL), Melco Crown Entertainment Limited (NASDAQ:MPEL), Albany Molecular Research Inc (NASDAQ:AMRI), Kulicke and Soffa Industries Inc (NASDAQ:KLIC), CYNOSURE INC (NASDAQ:CYNO), National Health Investors Inc (NYSE:NHI) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up Before earnings are released Thursday:
KLIC: 15.49 (-0.19), CYNO: 33.89 (+0.66), HALL: 11.27 (-0.01), MPEL: 21.99 (+0.07), NHI: 69.49 (+0.50), AMRI: 19.08 (+0.04)
Cynosure Shares Up 25.4% Since SmarTrend's Buy Recommendation (CYNO)
Comtex SmarTrend(R) - Thu Mar 12, 5:06PM CDT
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 5 months, Cynosure has returned 25.37% as of today's recent price of $28.66.
CYNO: 33.89 (+0.66)
Uptrend Call Working As Cynosure Stock Rises 36.7% (CYNO)
Comtex SmarTrend(R) - Thu Feb 19, 9:12AM CST
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 4 months, Cynosure has returned 36.70% as of today's recent price of $31.25.
CYNO: 33.89 (+0.66)
Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
AVP: 9.02 (+0.03), CYNO: 33.89 (+0.66), CS: 26.16 (-0.48), ATU: 23.89 (-0.38), CRK: 4.63 (-0.04)
Dermatology Devices Market worth $11,337.0 Million by 2019
M2 - Thu Feb 12, 8:19AM CST
"Major Players of Dermatology Devices Market are Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Genesis Biosystems, Inc. (U.S.), HEINE Optotechnik GmbH & Co. KG (Germany), Lumenis Ltd. (Israel), Michelson Diagnostics (U.K.), PhotoMedex, Inc. (U.S.), and Solta Medical, Inc. (U.S.)"The report segments the global dermatology devices market on the basis of applications, products, and geographies. he report provides a granular understanding of the dermatology devices market.
CYNO: 33.89 (+0.66), LMNS: 11.51 (+0.24), PHMD: 2.05 (+0.09)
Cynosure Up 34.1% Since SmarTrend Uptrend Call (CYNO)
Comtex SmarTrend(R) - Tue Feb 10, 5:00PM CST
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 4 months, Cynosure has returned 34.08% as of today's recent price of $30.65.
CYNO: 33.89 (+0.66)
Cynosure's (CYNO) CEO Mike Davin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 10, 2:07PM CST
CYNO: 33.89 (+0.66)
Cynosure (CYNO) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 10, 7:55AM CST
CYNO: 33.89 (+0.66)
Cynosure posts 4Q profit
Automated Insights - Tue Feb 10, 7:36AM CST
WESTFORD, Mass. (AP) _ Cynosure Inc. (CYNO) on Tuesday reported fourth-quarter earnings of $23 million.
CYNO: 33.89 (+0.66)
Cynosure misses by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 7:02AM CST
CYNO: 33.89 (+0.66)
Cynosure Reports Record Quarterly Revenue of $86.3 Million for the Fourth Quarter of 2014
PR Newswire - Tue Feb 10, 7:00AM CST
Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three and 12 months ended December 31, 2014.
CYNO: 33.89 (+0.66)
Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:30PM CST
WYN: 91.33 (+0.56), TLM: 7.89 (+0.01), CYNO: 33.89 (+0.66), PCG: 52.74 (+0.55), KKR: 23.39 (-0.15), GWR: 95.31 (-1.15), CDW: 38.87 (-0.15), ALLT: 8.68 (-0.25), HOT: 83.13 (-0.21), SAVE: 77.42 (+0.43), NSP: 50.80 (-0.91), MWW: 6.28 (-0.20), ACM: 33.18 (-0.22), DF: 16.83 (-0.03), REGN: 480.09 (+0.01), KO: 40.89 (-0.06), MLM: 138.53 (+0.29), RAI: 76.26 (-0.71), HCP: 42.45 (-0.12), SEE: 44.74 (-0.05), ENTG: 13.61 (-0.13), TAP: 75.13 (+0.01), ALR: 49.97 (-0.04), HNT: 58.28 (+0.41), OMC: 77.50 (-0.30), IMN: 4.16 (-0.11), SALE: 19.03 (+0.02), NILE: 28.37 (+0.87), CVS: 101.58 (+0.70), SFUN: 8.04 (-0.52)
Cynosure to Participate in Leerink Global Healthcare Conference
PR Newswire - Mon Feb 09, 7:30AM CST
Cynosure, Inc. (NASDAQ: CYNO) today announced that Chairman and Chief Executive Officer Michael Davin and Tim Baker, the Company's President and Chief Financial Officer, will participate in the Leerink Global Healthcare Conference in New York City.
CYNO: 33.89 (+0.66)
Shares of CYNO Up 33.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 03, 11:13AM CST
SmarTrend identified an Uptrend for Cynosure (NASDAQ:CYNO) on October 28th, 2014 at $22.86. In approximately 3 months, Cynosure has returned 33.38% as of today's recent price of $30.49.
CYNO: 33.89 (+0.66)
